Similarly, anti-inflammatory properties of allogeneic umbilical cord-derived MSCs, show improvements in patients with systemic sclerosis-associated, with better skin thickness scores, lung function, significantly decrease in anti-Scl70 autoantibody titers, and reduction of pro-inflammatory cytokine levels (including transforming growth factor-β (TGF-β) and vascular endothelial growth factor (VEGF) levels in serum) (Zhang et al., 2017). The gene discussed is VEGFA; the disease is systemic sclerosis.